FrancophonIA/ELRC3.0 huggingface dataset:
English: A significant increase in incidence of adenomas of the pancreatic islet was observed in male rats treated with 5 mg/kg/day guanfacine for 102 weeks but not in female rats.
Danish: Der blev observeret en signifikant forekomst af adenomer på de Langerhanske øer i pankreas hos hanrotter i behandling med 5 mg/kg/dag guanfacin i 102 uger, men ikke hos hunrotter.
English: • indigestion (dyspepsia)
Danish: • fordøjelsesbesvær (dyspepsi)
English: See section 4.2 for further dosing recommendations
Danish: 4.2 for yderligere doseringsvejledning
English: Guanfacine is cleared both by the liver and the kidneys, with approximately 30% of an intact medicinal product excreted with urine.
Danish: Guanfacin udskilles både af lever og nyrer, og ca. 30 % af det intakte lægemiddel udskilles via urinen.
English: Treatment of overdose may include gastric lavage if it is performed soon after ingestion.
Danish: Behandling af overdosering kan omfatte maveskylning, hvis det udføres umiddelbart efter indtagelse.
English: Serious adverse reactions commonly reported include hypotension (3.2%), weight increase (2.9%), bradycardia (1.5%) and syncope (uncommon) (0.7%).
Danish: Alvorlige, hyppigt rapporterede bivirkninger omfatter hypotension (3,2 %), vægtøgning (2,9 %), bradykardi (1,5 %) og synkope (ikke almindelig) (0,7 %).
English: The clinical relevance of this finding is uncertain.
Danish: Den kliniske relevans af dette fund er uvis.
English: It may have a moderate to severe influence on the ability to drive, use machines or cycling.
Danish: Det kan også påvirke evnen til at føre motorkøretøj, betjene maskiner eller cykle i moderat til svær grad.
English: In the data set from controlled, doubled blinded and open-label clinical studies with Intuniv the most frequently reported adverse reactions (very common) include somnolence (40.6%), headache (27.4%), fatigue (18.1%), abdominal pain upper (12.0%), and sedation (10.2%).
Danish: I datasættet fra kontrollerede, dobbelblindede og åbne kliniske studier med Intuniv omfatter de hyppigst rapporterede bivirkninger (meget almindelig) døsighed (40,6 %), hovedpine (27,4 %), træthed (18,1 %), øvre abdominalsmerter (12,0 %), og sedation (10,2 %).
English: This finding has no known clinical relevance.
Danish: Dette fund har ingen klinisk relevans.
English: Guanfacine is not an inhibitor of BSEP, MRP2, OATP1B1, OATP1B3, OAT1, OAT3, OCT2 or MATE2K, but it is an inhibitor of MATE1 and may be an inhibitor of OCT1 at maximal portal vein concentrations.
Danish: Guanfacin er ikke en hæmmer af BSEP, MRP2, OATP1B1, OATP1B3, OAT1, OAT3, OCT2 og MATE2K, men er en hæmmer af MATE1 og kan være en hæmmer af OCT1 ved den maksimale portåre-koncentration.
English: Guanfacine is a substrate of CYP3A4 and CYP3A5, and exposure is affected by CYP3A4 and CYP3A5 inducers and inhibitors.
Danish: Guanfacin er et substrat for CYP3A4 og CYP3A5, og eksponeringen påvirkes af CYP3A4- og CYP3A5-inducere og -hæmmere.
English: Length of treatment
Danish: Behandlingsvarighed
English: No adverse effects were observed in a fertility study in female rats at doses up to 22 times the maximum recommended human dose on a mg/m basis.
Danish: Der blev ikke observeret nogen bivirkninger i et fertilitetsstudie med hunrotter ved doser op til 22 gange den maksimalt anbefalede dosis til mennesker baseret på mg/m
English: Guanfacine
Danish: Guanfacin
English: In this 12-week (6-12 years) or 15-week (13-17 years), randomised, double-blind, parallel-group, placebo- and active-reference (atomoxetine), dose-titration study, guanfacine showed significantly greater efficacy than placebo on symptoms of ADHD based upon investigator ratings on the ADHD Rating Scale (ADHD-RS).
Danish: I dette 12-ugers (6 til 12 år) eller 15-ugers (13 til 17 år) randomiserede, dobbeltblinde dosistitreringsstudie med parallelle grupper med placebo og aktivt referencestof (atomoxetin) viste guanfacin signifikant større virkning end placebo på symptomer af ADHD, baseret på investigatorernes klassifikation på ADHD klassifikationsskalaen (ADHD-RS).
English: It was designed to evaluate the efficacy and safety of guanfacine (1, 2, 3, and 4 mg/day) when co-administered with long-acting psychostimulants (amphetamine, lisdexamphetamine, methylphenidate, dexmethylphenidate) in children and adolescents aged 6-17 years with a diagnosis of ADHD and a suboptimal, partial response to psychostimulants.
Danish: Det var designet til at evaluere guanfacins virkning og sikkerhed (1, 2, 3 og 4 mg/dag) ved administration sammen med langtidsvirkende psykostimulantia (amfetamin, lisdexamfetamin, methylphenidat, dexmethylphenidat) hos børn og unge i alderen 6-17 år med en diagnose på ADHD og et suboptimalt, delvist respons på psykostimulantia.
English: Adverse Drug Reactions Reported with Intuniv System/Organ Class
Danish: Bivirkninger rapporteret med Intuniv Systemorganklasse
English: • increase in blood pressure
Danish: • blodtryksstigning
English: The effect of 2 dose levels of immediate-release guanfacine (4 mg and 8 mg) on QT interval was evaluated in a double-blind, randomised, placebo- and active-controlled, cross-over study in healthy adults.
Danish: Virkningen af 2 dosisniveauer på guanfacin med øjeblikkelig udløsning (4 mg og 8 mg) på QTintervallet blev evalueret i et dobbeltblindet, randomiseret overkrydsningsstudie med placebo og aktiv kontrol hos raske voksne.
English: Guanfacine showed significantly greater improvement compared to placebo on the change from baseline to final on treatment assessment in the ADHD Rating Scale (ADHD-RS-IV) score in both studies (placebo-adjusted reduction in LS mean range from 5.4 to 10.0, p<0.02).
Danish: Guanfacin viste signifikant større forbedring sammenlignet med placebo på ændringen fra baseline til den sidste dosis under behandling i score på ADHD klassifikationsskala (ADHD-RS-IV) i begge studier (placebojusteret reduktion i mindste kvadraters gennemsnitlige interval fra 5,4 til 10,0, p<0,02).
English: • feeling dizzy when standing up (postural dizziness)
Danish: • svimmelhedsfølelse, når man rejser sig op (postural svimmelhed)
English: Superiority (statistical significance) over placebo on the family and school, and learning domains of the WFIRS-P score was not established in this study.
Danish: Superioritet (statistisk signifikans) i forhold til placebo, hvad angår familie og skole og indlæringsdomæner for WFIRS-P-score, blev ikke klarlagt i dette studie.
English: When patients are taking Intuniv concomitantly with a CYP3A4 inducer, an increase in the dose of Intuniv within the recommended dose range is proposed (see section 4.2).
Danish: Når patienterne tager Intuniv samtidigt med en CYP3A4-inducer, foreslås en forhøjelse af Intunivdosis inden for det anbefalede dosisinterval (se pkt.
English: When Intuniv is used concomitantly with CYP3A4/5 inhibitors or inducers, plasma concentrations of guanfacine may be elevated or lowered, potentially affecting the efficacy and safety of Intuniv.
Danish: Når Intuniv anvendes sammen med CYP3A4/5-hæmmere eller -inducere, kan plasmakoncentrationerne af guanfacin være forhøjet eller nedsat, hvilket muligvis kan påvirke Intunivs virkning og sikkerhed.
English: Guanfacine should be prescribed with caution in patients with a known history of QT prolongation, risk factors for torsade de pointes (e.g., heart block, bradycardia, hypokalaemia) or patients who are taking medicinal products known to prolong the QT interval.
Danish: Guanfacin skal ordineres med forsigtighed til patienter med kendt tidligere QT-forlængelse, risikofaktorer for torsade de pointes (f.eks. hjerteblok, bradykardi, hypokaliæmi) eller patienter, der tager lægemidler, som vides at forlænge QT-intervallet.
English: Intuniv may affect your weight and height if taking for long periods, your doctor will therefore monitor your growth.
Danish: Intuniv kan påvirke din vægt og højde, hvis du tager det i lange perioder.
English: Intuniv can increase plasma concentrations of concomitantly administered medicinal products that are metabolised via CYP3A4/5 (see sections 4.2, 4.4 and 5.2).
Danish: Intuniv kan øge plasmakoncentrationerne af samtidigt administrerede lægemidler, der metaboliseres via CYP3A4/5 (se pkt.
English: Caution should be used when Intuniv is administered concomitantly with antihypertensive medicinal products, due to the potential for additive pharmacodynamic effects such as hypotension and syncope.
Danish: Der bør udvises forsigtighed, når Intuniv administreres sammen med antihypertensiva, da der er mulighed for additive farmakodynamiske virkninger, såsom hypotension og synkope.
English: Symptoms of ADHD were evaluated as the change from baseline to week 8 (final on treatment assessment) in the ADHD Rating Scale (ADHD-RS-IV) total scores.
Danish: Symptomer på ADHD blev udført som ændringen fra baseline til uge 8 (sidste dosis under behandlingen) på ADHD klassifikationsskalaen (ADHD-RS-IV) totale scores.
English: This evaluation should address a patient's cardiovascular status including blood pressure and heart rate, documenting comprehensive history of concomitant medications, past and present co-morbid medical and psychiatric disorders or symptoms, family history of sudden cardiac/unexplained death and accurate recording of pre-treatment height and weight on a growth chart (see section 4.4).
Danish: Denne evaluering skal omfatte en patients kardiovaskulære status, herunder blodtryk og puls, dokumentere en omfattende anamnese over samtidige lægemidler, tidligere og aktuelle komorbide medicinske og psykiatriske lidelser eller symptomer, familiær anamnese med pludselig hjertedød/uforklaret død og akkurat registrering af højde og vægt før behandlingen på en vækstkurve (se pkt.
English: The pharmacodynamic effect of Intuniv can have an additive effect when taken with other products known to cause sedation, hypotension or QT prolongation (see section 4.4).
Danish: Intunivs farmakodynamiske virkning kan have en additiv virkning, når lægemidlet tages sammen med andre præparater, der vides at forårsage sedation, hypotension eller QT-forlængelse (se pkt.
English: Results show statistically significantly (p≤0.05) greater mean reductions at endpoint from Baseline (indicating improvement) in oppositional subscale of CPRS-R:L scores in the guanfacine group compared to placebo (10.9 points vs. 6.8 for guanfacine vs. placebo, respectively) and the effect size was 0.6 (p<0.001).
Danish: Resultaterne viser statistisk signifikant (p≤0,05) større gennemsnitlige reduktioner ved endepunktet fra baseline (hvilket indikerer forbedring) i oppositionsdelskalaen af CPRS-R:Lscores i guanfacingruppen, sammenlignet med placebo (10,9 points vs. 6,8 for hhv. guanfacin vs. placebo), og virkningsstørrelsen var 0,6 (p<0,001).
English: The major urinary metabolites were 3-hydroxy guanfacine glucuronide, guanfacine dihydrodiol, 3-hydroxy guanfacine sulphate.
Danish: De primære metabolitter i urinen var 3-hydroxyguanfacinglucuronid, guanfacindihydrodiol, 3-hydroxyguanfacinsulfat.
English: Other medicines and Intuniv
Danish: Brug af anden medicin sammen med Intuniv
English: Monitoring of heart rate and blood pressure parameters should continue on a weekly basis during dose titration and stabilisation and at least every 3 months for the first year, taking into consideration clinical judgement.
Danish: Overvågning af puls og blodtryksparametre bør fortsætte ugentligt i løbet af dosistitrering og stabilisering samt mindst hver 3. måned i løbet af det første år efter klinisk bedømmelse tages i betragtning.
English: Psychiatric disorders Depression
Danish: Psykiske forstyrrelser Depression
English: Study SPD503-314 was conducted in children aged 6-12 years to assess the efficacy of once daily dosing with guanfacine (1-4 mg) administered either in the morning or the evening.
Danish: Studie SPD503-314 blev udført hos børn i alderen 6-12 år for at vurdere virkningen af dosering en gang dagligt med guanfacin (1-4 mg) administreret enten om morgenen eller om aftenen.
English: 31-January-2022
Danish: Indsendelse af endelig studierapport: 31. januar 2022
English: Respiratory, thoracic, and mediastinal disorders Asthma
Danish: Luftveje, thorax og mediastinum Astma
English: Crospovidone Type A Microcrystalline cellulose Silica, colloidal anhydrous Sodium laurilsulphate Polysorbate 80
Danish: Crospovidon Type A Mikrokrystallinsk cellulose Silica, kolloid vandfri Natriumlaurilsulfat Polysorbat 80
English: Patients treated with CYP3A4 and CYP3A5 inhibitors/inducers CYP3A4/5 inhibitors have been shown to have a significant effect on the pharmacokinetics of guanfacine when co-administered.
Danish: Patienter i behandling med CYP3A4- og CYP3A5-hæmmere/-inducere CYP3A4/5-hæmmere har vist sig at have en signifikant virkning på guanfacins farmakokinetik ved samtidig administration.
English: • fast heart beat (tachycardia)
Danish: • hurtigt hjerteslag (takykardi)
English: Atomoxetine
Danish: Atomoxetin
English: The study was double-blind, randomised, placebo-controlled, multi-centre, dose-optimisation 9-weeks study.
Danish: Studiet var et dobbeltblindet, randomiseret, placebokontrolleret, 9-ugers multicenterstudie med henblik på dosisoptimering.
English: If you stop taking Intuniv
Danish: Hvis du holder op med at tage Intuniv
English: Careful dose titration and monitoring is necessary at the start of treatment with Intuniv since clinical improvement and risks for several clinically significant adverse reactions (syncope, hypotension, bradycardia, somnolence and sedation) are dose- and exposure-related.
Danish: Det er nødvendigt med en nøje dosistitrering og -overvågning ved begyndelsen af behandlingen med Intuniv, da klinisk forbedring og risici for flere klinisk signifikante bivirkninger (synkope, hypotension, bradykardi, døsighed og sedation) er dosis- og eksponeringsrelaterede.
English: Investigations Blood pressure decreased
Danish: Undersøgelser Nedsat blodtryk
English: • trouble breathing (asthma)
Danish: • vejrtrækningsproblemer (astma)
English: Co-administration of Intuniv with moderate and strong CYP3A4/5 inhibitors elevates plasma guanfacine concentrations and increases the risk of adverse reactions such as hypotension, bradycardia, and sedation.
Danish: Administration af Intuniv sammen med moderate og kraftige CYP3A4/5-hæmmere øger plasmakoncentrationen af guanfacin og øger risikoen for bivirkninger, såsom hypotension, bradykardi og sedation.
English: (statistical significance) over placebo on the family and school, and learning domains of the WFIRS-P score was not consistently established in this study.
Danish: Superioritet (statistisk signifikans) i forhold til placebo for familie og skole samt indlæringsdomæner for WFIRS-P-score var ikke konsekvent klarlagt i dette studie.
English: • need to urinate frequently (pollakiuria)
Danish: • hyppig vandladningstrang (pollakisuri)
English: Co-administration of Intuniv and valproic acid can result in increased concentrations of valproic acid.
Danish: Administration af Intuniv sammen med valproinsyre kan føre til forhøjede koncentrationer af valproinsyre.
English: If you suddenly stop taking Intuniv, you may develop withdrawal symptoms of increased heart rate and high blood pressure (see section 4).
Danish: Hvis du pludselig holder op med at tage Intuniv, kan du få abstinenssymptomer som forhøjet hjertefrekvens og forhøjet blodtryk (se pkt.
English: If guanfacine is combined with strong enzyme inducers, a retitration to increase the dose up to a maximum daily dose 7 mg (see section 4.2), may be considered if needed.
Danish: Hvis guanfacin kombineres med kraftige enzyminducere kan det overvejes at gentage titreringen for at øge dosis til den maksimale daglige dosis på 7 mg (se pkt.
English: • feeling depressed, worried (anxiety) or having mood swings (affect lability)
Danish: • depression, bekymringer (angst) eller humørsvingninger (affektlabilitet)
English: Dose adjustment is recommended with concomitant use of moderate/strong CYP3A4/5 inhibitors (e.g., ketoconazole, grapefruit juice), or strong CYP3A4 inducers (e.g., carbamazepine) (see section 4.5).
Danish: Der anbefales dosisreduktion ved samtidig anvendelse af moderate/kraftige CYP3A4/5-hæmmere (f.eks. ketoconazol, grapefrugtjuice) eller kraftige CYP3A4-inducere (f.eks. carbamazepin) (se pkt.
English: Animal studies indicate an effect on male fertility (see section 5.3).
Danish: Dyrestudier indikerer en virkning på fertiliteten hos hanner (se pkt.
English: In a maintenance of efficacy study, upon switching from guanfacine to placebo, 7/158 (4.4%) subjects experienced increases in blood pressure to values above 5 mmHg and also above the 95
Danish: I et vedligeholdelsesstudie med skift fra guanfacin til placebo oplevede 4,4 % af forsøgspersonerne (7/158) stigninger i blodtrykket til over 5 mmHg, hvilket også lå over 95-percentilen for alder, køn og statur (se pkt.
English: Sedation and somnolence
Danish: Sedation og døsighed
English: The Educational material and Prescriber checklist shall contain the following key messages:
Danish: • Uddannelsesmateriale (herunder tjekliste for ordinerende person) for sundhedspersonale Uddannelsesmaterialet og tjeklisten for ordinerende person skal indeholde de følgende nøglebeskeder:
English: If you forget to take Intuniv
Danish: Hvis du har glemt at tage Intuniv
English: QT Prolonging medicinal products
Danish: Lægemidler, der forårsager QT-forlængelse
English: • psychological therapy
Danish: • psykoterapi
English: Alanine aminotransferase increased
Danish: Forhøjet ALAT (alaninaminotransferase)
English: The physician who elects to use guanfacine for extended periods (over 12 months) should re-evaluate the usefulness of guanfacine every 3 months for the first year and then at least yearly based on clinical judgement (see section 4.4), and consider trial periods off medication to assess the patient's functioning without pharmacotherapy, preferably during times of school holidays.
Danish: Lægen, som vælger at anvende guanfacin i længere perioder (over 12 måneder), bør reevaluere nytten af guanfacin hver 3. måned i løbet af det første år og derefter mindst årligt baseret på klinisk bedømmelse (se pkt.
English: Very rare: a serious withdrawal side effect of high blood pressure after suddenly stopping Intuniv; symptoms may include headaches, feeling confused, nervousness, agitation, and tremors (hypertensive encephalopathy).
Danish: Meget sjælden: en alvorlig ophørsbivirkning i form af forhøjet blodtryk ved pludseligt ophør med Intuniv; symptomerne kan være hovedpine, forvirring, nervøsitet, uro og rystelser (hypertensiv encefalopati).
English: Caution should be used when Intuniv is administered concomitantly with CNS depressant medicinal products (e.g., alcohol, sedatives, hypnotics, benzodiazepines, barbiturates, and antipsychotics) due to the potential for additive pharmacodynamic effects such as sedation and somnolence.
Danish: Der bør udvises forsigtighed, når Intuniv administreres sammen med CNS-undertrykkende lægemidler (f.eks. alkohol, sedativa, hypnotika, benzodiazepiner, barbiturater og antipsykotika), da der er mulighed for additive farmakodynamiske virkninger, såsom sedation og døsighed.
English: Intuniv contains lactose:
Danish: Intuniv indeholder lactose:
English: Methacrylic acid-Ethyl acrylate copolymer Lactose monohydrate Povidone
Danish: Methacrylsyre-ethylacrylat copolymer Lactosemonohydrat Povidon
English: In post-marketing experience, hypertensive encephalopathy has been very rarely reported upon abrupt discontinuation of Intuniv (see section 4.4).
Danish: Efter markedsføringen er der rapporteret om meget sjældne tilfælde af hypertensiv encefalopati efter brat seponering af Intuniv (se pkt.
English: CYP3A4 inducers
Danish: CYP3A4-inducere
English: In addition 3 mg and 4 mg tablets include Indigo carmine aluminium lake E 132 Iron oxide yellow E 172
Danish: Desuden indeholder tabletter med 3 mg og 4 mg Indigocarmin aluminium lake E 132
English: Caution is advised when treating patients with Intuniv who have a history of hypotension, heart block, bradycardia, or cardiovascular disease, or who have a history of syncope or a condition that may predispose them to syncope, such as hypotension, orthostatic hypotension, bradycardia, or dehydration.
Danish: Der bør udvises forsigtighed ved behandling af patienter med tidligere hypotension, hjerteblok, bradykardi eller kardiovaskulær sygdom, eller som tidligere har haft synkope eller en tilstand, der kan disponere dem for synkope, såsom hypotension, ortostatisk hypotension, bradykardi eller dehydrering.
English: Therefore, monitoring of height, weight and BMI should be done prior to initiation of therapy and then every 3 months for the first year, taking into consideration clinical judgement.
Danish: Derfor skal højde, vægt og BMI sted overvåges, før behandlingen påbegyndes, og dernæst hver 3. måned i løbet af det første år efter klinisk bedømmelse tages i betragtning.
English: Prior to initiation of treatment, patient's cardiovascular status including heart rate and blood pressure parameters, family history of sudden cardiac death /unexplained death, should be assessed to identify patients at increased risk of hypotension, bradycardia, and QT-prolongation/risk of arrhythmia.
Danish: Før behandlingen påbegyndes, skal patientens kardiovaskulære status vurderes, herunder puls og blodtryksparametre, familiær anamnese med pludselig hjertedød/uforklaret dødsfald, for at identificere patienter med en øget risiko for hypotension, bradykardi og QT-forlængelse/risiko for arytmi.
English: • a serious withdrawal side effect of high blood pressure after suddenly stopping Intuniv; symptoms may include headaches, feeling confused, nervousness, agitation, and tremors (hypertensive encephalopathy).
Danish: • en alvorlig ophørsbivirkning i form af forhøjet blodtryk ved pludseligt ophør med Intuniv; symptomerne kan være hovedpine, forvirring, nervøsitet, uro og rystelser (hypertensiv encefalopati).
English: • itchy skin (pruritus)
Danish: • hudkløe (pruritus)
English: Given the effect of Intuniv on heart rate, the concomitant use of Intuniv with QT prolonging medicinal products is generally not recommended (see section 4.4).
Danish: Når virkningen af Intuniv på pulsen tages i betragtning, anbefales anvendelse af Intuniv sammen med lægemidler, der forårsager QT-forlængelse, normalt ikke (se pkt.
English: Consequently, as part of routine monitoring height, weight and BMI should be monitored at the start of treatment and every 3 months during the first year, then 6 monthly taking in to consideration clinical judgement with maintenance of a growth chart.
Danish: Som følge heraf bør højde, vægt og BMI overvåges ved behandlingsstart og hver 3. måned i løbet af det første år som en del af en rutinemæssig overvågning, og dernæst hver 6. måned efter klinisk bedømmelse tages i betragtning med registrering på en vækstkurve.
English: Weight Group Week 1 Week 2 Week 3 Week 4 25 kg and up
Danish: Uge 1 Uge 2 Uge 3 Uge 4
English: Cardiac disorders Bradycardia
Danish: Hjerte Bradykardi
English: Intuniv causes a decrease in heart rate.
Danish: Intuniv sænker pulsen.
English: Change from baseline (SD)
Danish: Ændring fra baseline
English: Three hundred and thirty-seven patients aged 6-17 years were evaluated in the pivotal Phase 3 Study SPD503-316, to assess safety and efficacy of once-daily dosing (children:1-4mg/day, adolescents: 1-7 mg/day).
Danish: 337 patienter i alderen 6-17 år blev evalueret i det pivotale fase III-studie SPD 503-316 for at vurdere sikkerhed og virkning af dosering en gang dagligt (børn:1-4 mg/dag, unge:1-7 mg/dag).
English: Study SPD503-307 was a 9-week, double-blind, randomised, placebo-controlled, dose-optimisation study with guanfacine (1-4 mg/day) conducted in children aged 6-12 years with ADHD and oppositional symptoms (n=217).
Danish: Studie SPD503-307 var et 9-ugers, dobbeltblindet, randomiseret, placebokontrolleret studie med henblik på dosisoptimering med guanfacin (1-4 mg/dag), udført hos børn i alderen 6-12 år med ADHD og oppositionssymptomer (n=217).
English: What you need to know before you take Intuniv
Danish: Det skal du vide, før du begynder at tage Intuniv
English: Abdominal/stomach discomfort
Danish: Abdominal/mavebesvær
English: OTHER SPECIAL WARNING(S), IF NECESSARY
Danish: 4.2), hvis det er nødvendigt.
English: 49.5-58.4 kg Max
Danish: 49,5-58,4 kg Maks.